Jefferies Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,500
Closed -$1.45M 1937
2025
Q4
$1.45M Buy
+21,500
New +$1.45M 0.01% 932
2024
Q1
Sell
-74,200
Closed -$2.74M 1776
2023
Q4
$2.74M Buy
74,200
+25,400
+52% +$957K 0.02% 592
2023
Q3
$1.86M Sell
48,800
-49,200
-50% -$2.02M 0.02% 645
2023
Q2
$3.53M Buy
+98,000
New +$3.34M 0.03% 470

Other funds holding HALO

Jefferies Financial Group's HALO Position: Q1 2026 in Review

Jefferies Financial Group increased its Halozyme (HALO) stake by 19% in Q1 2026, buying an estimated $358K and bringing the position to 32,000 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #632.

Jefferies Financial Group first reported a position in HALO in Q2 2023 and has held it in 5 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Jefferies Financial Group held 32,000 shares of Halozyme worth $2.07M as of Q1 2026.
  • Jefferies Financial Group bought 5,075 Halozyme shares in Q1 2026, an estimated $358K.
  • Halozyme made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #632 holding.
  • Jefferies Financial Group first reported a position in Halozyme in Q2 2023 and has held it in 5 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.